Latest News

Allergy Therapeutics, a biotechnology company specialising in the treatment and diagnosis of allergic disorders, has announced the first application of VLP Peanut in peanut allergic patients has commenced.

The Food Standards Agency is seeking views on new advice for how and when to apply precautionary allergen labelling (PAL).

Imperial College London is offering up to five scholarships for UK or international applicants for the next academic year 2023-2024.

‘The Hope Hoot’, returning for its second year following a three-year hiatus, will be raising money and awareness for two allergy charities, Allergy UK and Anaphylaxis UK.

A new analysis that looked at the optimal timing of introducing peanut products to babies to prevent peanut allergy suggests that a 77% reduction in peanut allergy could be achieved if peanut was introduced to all babies at four to six months of age. 

Following a scientific review of the safety of pholcodine, the Medicines and Healthcare products Regulatory Agency (MHRA), with advice from the independent Commission on Human Medicines, has recommended that all pholcodine-containing cough and cold medicines should be withdrawn as a precautionary measure. 

The Affidia Journal will be hosting an online webinar entitled Precautionary Allergen Labelling (PAL): What lies ahead on 23 March, 3 – 5pm.

For many people, Easter is the time of year for indulging in chocolate and all kinds of other sweet treats.

We are moving our AllergyWise® courses to our new learning platform on the Anaphylaxis UK website. The new platform provides a smoother training experience and features our updated and improved AllergyWise® for Schools course.